Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Introduction: We investigated the clinical differences between familial and sporadic frontotemporal dementia (FTD), screening for mutations in known FTD genes. Methods: We diagnosed 22 affected individuals belonging to eight families and 43 sporadic cases with FTD in Apulia, Southern Italy, in 2 years. Mutations in common causative FTD genes (GRN, MAPT, VCP, and TARDBP) and C9ORF72 expansions were screened. Results: Behavioral variant of FTD was the most common clinical subtype (50% and 69% in familial and sporadic cases, respectively). Social conduct impairment/disinhibition, loss of insight, and inflexibility were the most frequent clinical features observed at onset. One new mutation was identified in GRN in family A. Discussion: Disease onset in sporadic FTD was more frequently characterized by a clustering of behavioral symptoms with apathy and loss of personal hygiene. Mutations in common causative FTD genes are not a major cause of familial and sporadic FTD in the Southern Italian population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
<emph type="ital">SQSTM1</emph> Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Fecto, F. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.250 · Cited by 650
The heritability and genetics of frontotemporal lobar degeneration
Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536
Clinical staging and disease progression in frontotemporal dementia
Mioshi, E., Hsieh, S., Savage, S., Hornberger, M., & Hodges, J. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04070 · Cited by 362
Guerreiro, R., Bilgic, B., Guven, G., Brás, J., Rohrer, J., Lohmann, E., Hanagasi, H., Gurvit, H., & Emre, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.005 · Cited by 158 · cited 1×
“The screening for mutations in other uncommon FTD genes such as the charged multivesicular body protein 2B (CHMP2B) [42], FUS [43,44], dynactin (DCTN1) [45], sequestosome 1 (SQSTM1) [46], colonystimulating factor 1 receptor (CFS1R) [47], triggering receptor expressed on myeloid cells (TREM2) [48], ubiquilin-2 (UBQLN2)…”
BackgroundLandin-Romero, R., Kumfor, F., Leyton, C. E., Irish, M., Hodges, J. R., & Piguet, O. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.03.032 · Cited by 116 · cited 1×
“The identification of clinical and imaging milestones may also represent a useful tool in the future to monitor drug efficacy and their ability to modulate disease progression [28].”
BackgroundThe FReJA consortium, Clayton, E. L., Mizielinska, S., Edgar, J. R., Nielsen, T. T., Marshall, S., Norona, F. E., Robbins, M., Damirji, H., Holm, I. E., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1475-3 · Cited by 96
Cited by
Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview
Sivandzade, F., & Cucullo, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042153 · Cited by 224
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
Self-citationHeuer, H. W., Wang, P., Rascovsky, K., Wolf, A., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., Brushaber, D. E., Caso, C., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12046 · Cited by 43
Benussi, A., Libri, I., Premi, E., Alberici, A., Cantoni, V., Gadola, Y., Rivolta, J., Pengo, M., Gazzina, S., Calhoun, V. D., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12326 · Cited by 14
Metadata
- Authors
- Capozzo, R., Sassi, C., Hammer, M. B., Arcuti, S., Zecca, C., Barulli, M. R., Tortelli, R., Gibbs, J. R., Crews, C., Seripa, D., Carnicella, F., Dell'Aquila, C., Rossi, M., Tamma, F., Valluzzi, F., Brancasi, B., Panza, F., Singleton, A. B., & Logroscino, G.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2017-03-03
- Volume
- 13
- Issue
- 8
- Pages
- 858-869
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2594636964
- Cited by
- 33
- References
- 7
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy. https://app.cochat.ai/papers/10.1016/j.jalz.2017.01.011
- The paper
- Capozzo, R., Sassi, C., Hammer, M. B., Arcuti, S., Zecca, C., Barulli, M. R., Tortelli, R., Gibbs, J. R., Crews, C., Seripa, D., Carnicella, F., Dell'Aquila, C., Rossi, M., Tamma, F., Valluzzi, F., Brancasi, B., Panza, F., Singleton, A. B., & Logroscino, G. (2017). Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2017.01.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.